Samsung Signs Contract to Purchase Stake in Ultrasound Maker Medison

- Investment come as part of strategic focus on medical devices

뉴스 제공

삼성전자 코스피 005930

2010-12-14 10:37

SEOUL--(뉴스와이어)--Samsung Electronics Co., Ltd, a global technology innovation and digital convergence leader, today announced it has signed an agreement with Consus Asset Management Co., Ltd. to purchase stake in leading diagnostic ultrasound manufacturer Medison Co., Ltd., as part of its long-term strategic expansion into the medical devices business.

Under the contract, Samsung Electronics will acquire a 43.5 percent stake in Medison, as well as 100 percent of Prosonic Co., Ltd., a manufacturer of transducer probes and cables for ultrasound devices. The investment contract is contingent upon resolution by the court of a preliminary injunction on the disposal of part of the stake in Medison.

As part of Samsung’s long-term plan to develop next-generation growth engines, the company announced earlier this year that it will invest 1.2 trillion won through 2020 in expanding into the healthcare equipment business, with an initial focus on diagnostics tools.

The ultrasound diagnostics device segment provided a logical entry point into the healthcare equipment market due to technological similarities and potential synergies with Samsung’s existing consumer electronics and IT products and technologies.

“We aim to combine Medison’s expertise and advanced technology in diagnostics ultrasound devices with Samsung’s resources, global network, design and other technological capabilities to create differentiated medical diagnostic solutions for the global market,” said Sangwon Bang, Senior Vice President and Head of the Health & Medical Equipment (HME) Business Team, Samsung Electronics.

“With Samsung Electronics’ investment, Medison will be strongly positioned to grow into a leader in the medical devices market,” said Consus Asset Management Chairman Youngjae Kim.

Samsung unveiled its first healthcare equipment product offering in June this year – a portable, professional-use blood analysis device, initially available in the South Korean market.

삼성전자 개요
삼성전자는 반도체, 통신, 디지털 미디어와 디지털 컨버전스 기술을 보유한 글로벌 리더다. 삼성전자는 디지털 어플라이언스 부문, 디지털 미디어 부문, LCD 부분, 반도체 부문, 통신 네트워크 부문 등 5개 부문으로 이뤄져 있다. 세계에서 가장 빠르게 성장하는 브랜드인 삼성전자는 스마트폰, 디지털 TV, 메모리 반도체, OLED, TFT-LCD 분야에서 세계 선두 주자다.

웹사이트: http://www.samsung.com/sec